RECRUITING

Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to compare whether the FDA and Health Canada approved microUS is as effective as the currently used option (MRI) for imaging the prostate gland. Participants will be randomized into two groups to compare the imaging results of the current standard of care MRI and the new microUS. The study is looking to identify the most effective imaging modality to help guide whether you progress to have a prostate biopsy.

Official Title

A Phase 3, Multicenter, International, Non-inferiority, Randomized Clinical Trial Comparing Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging (MUSIC-Screen)

Quick Facts

Study Start:2025-05-08
Study Completion:2029-11-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06626022

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:50 Years to 70 Years
Sexes Eligible for Study:MALE
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Male sex;
  2. 2. Age 50-70;
  3. 3. PSA 3-20 and/or abnormal DRE;
  4. 4. Biopsy naïve.
  1. 1. Prior personal history of prostate cancer;
  2. 2. Prior prostate imaging using microUS or MRI;
  3. 3. Contraindication to microUS or MRI;
  4. 4. Testosterone replacement therapy within last 12 months; or
  5. 5. Androgen deprivation therapy within last 12 months.

Contacts and Locations

Study Contact

Adam Kinnaird, MD, PhD
CONTACT
+1-780-407-5800
ask@ualberta.ca

Study Locations (Sites)

University of California, Los Angeles (UCLA)
Los Angeles, California, 90095
United States

Collaborators and Investigators

Sponsor: University of Alberta

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-05-08
Study Completion Date2029-11-30

Study Record Updates

Study Start Date2025-05-08
Study Completion Date2029-11-30

Terms related to this study

Additional Relevant MeSH Terms

  • Prostate Cancer Screening